SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-035280
Filing Date
2020-11-05
Accepted
2020-11-05 16:08:22
Documents
48
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0920_inmunebioinc.htm 10-Q 608340
2 AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT f10q0920ex10-1_inmunebio.htm EX-10.1 24253
3 CERTIFICATION f10q0920ex31-1_inmunebio.htm EX-31.1 14695
4 CERTIFICATION f10q0920ex31-2_inmunebio.htm EX-31.2 14668
5 CERTIFICATION f10q0920ex32-1_inmunebio.htm EX-32.1 6734
6 CERTIFICATION f10q0920ex32-2_inmunebio.htm EX-32.2 5030
  Complete submission text file 0001213900-20-035280.txt   3138198

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE inmb-20200930.xml EX-101.INS 383278
8 XBRL SCHEMA FILE inmb-20200930.xsd EX-101.SCH 46156
9 XBRL CALCULATION FILE inmb-20200930_cal.xml EX-101.CAL 23754
10 XBRL DEFINITION FILE inmb-20200930_def.xml EX-101.DEF 198220
11 XBRL LABEL FILE inmb-20200930_lab.xml EX-101.LAB 382100
12 XBRL PRESENTATION FILE inmb-20200930_pre.xml EX-101.PRE 199677
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 201290480
SIC: 2836 Biological Products, (No Diagnostic Substances)